DOI 10.1016/j.cancergen.2026.04.003
Outcomes of TSHR mutations in indeterminate thyroid nodules.
Аннотация
BACKGROUND
The thyrotropin receptor (TSHR) mutation can be present in autonomously functioning thyroid nodules (AFTNs). Our objective was to evaluate whether patients with a TSHR mutation developed AFTNs and to assess the impact of this mutation on thyroid malignancy.
METHODS
We conducted a multicenter retrospective study of 1211 patients from Montreal, Canada, and from Tel Aviv, Israel, who underwent molecular testing (ThyroseqV3®) from January 2018 to December 2022 following an indeterminate cytology result (Bethesda III-IV). All TSHR-positive patients (n = 56) and 90 randomly selected mutation-negative patients were included. TSH levels were measured at least twice over 1-3 years following molecular testing.
RESULTS
The case group was predominantly female (94.8%) with a mean age of 51.2 years. The mean TSH levels in the control and case groups were 2.29 (CI=95% 1.93-2.66) and 1.55 (CI=95% 1.23-1.86) at first follow-up, and 2.17 (CI=95% 1.80-2.54) and 1.33 (CI=95% 1.01-1.66) at second follow-up. Higher allele frequency correlated with lower TSH levels (P = 0.005, P = 0.002). All isolated TSHR mutations were associated with benignity regardless of allele frequency, while co-occurring genetic alterations were associated with malignant outcomes.
CONCLUSIONS
TSHR mutations are generally benign and correlate with lower TSH levels. Co-mutations may influence thyroid function and malignancy risk.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.